x
- Home
- About Diabetes
- Services
- Diabetes Mellitus Modeling Solutions
- R&D Services for Diabetes Mellitus and Diabetic Complications
- By Drug Development Process
- About Us
- Careers
- Contact Us
Cat. No.: DAA-001144
| Product Information | |
|---|---|
| Product Name | Horse IL-1α ELISA Kit |
| Species | Horse |
| Description | Horse IL-1α ELISA Kit is designed for the quantitative determination of Horse IL-1α in cell culture supernatants, plasma and serum samples. This assay employs an antibody specific for IL-1α coated on a 96-well plate. Standards and samples are pipetted into the wells and IL-1α present in a sample is bound to the wells by the immobilized antibody. The wells are washed and biotinylated anti-Horse IL-1α antibody is added. After washing away unbound biotinylated antibody, HRP-conjugated streptavidin is pipetted to the wells. The wells are again washed, a TMB substrate solution is added to the wells and color develops in proportion to the amount of IL-1α bound. |
| Sample Types | Cell Culture Supernatant, Serum, Plasma |
| Detection Range | 0.82 pg/mL - 200 pg/mL |
| Sensitivity | 0.82 pg/mL |
| Target Information | |
|---|---|
| Target Name | IL1A |
| UniProt No. | P01583 |
| Gene ID | 3552 |
| Target Description | Produced by activated macrophages, IL-1 stimulates thymocyte proliferation by inducing IL-2 release, B-cell maturation and proliferation, and fibroblast growth factor activity. IL-1 proteins are involved in the inflammatory response, being identified as endogenous pyrogens, and are reported to stimulate the release of prostaglandin and collagenase from synovial cells. |
| Alternative Names | BAF; FAF; Hematopoietin 1; Hematopoietin-1; IL 1α; IL 1A; IL-1α; Il-1a; IL1; IL1α; IL1A; IL1A_HUMAN; IL1F1; Interleukin 1α; Interleukin-1α; Interleukin1α; LAF; LEM; Preinterleukin 1α; Pro interleukin 1α |
| Shipping & Storage | |
|---|---|
| Sipping | Shipping on dry ice. |
| Storage | Store at -20°C. Please refer to protocols. |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.
